Large-scale Real-time Reverse Transcription-PCR Approach of Angiogenic Pathways in Human Transitional Cell Carcinoma of the Bladder: Identification of VEGFA as a Major Independent Prognostic Marker

European Urology

Volumn 56, Issue 4, 2009, Pages 678-689

  Pignot, Géraldine ^a   Bieche, Ivan ^b   Vacher, Sophie ^b   Güet, Catherine ^b   Vieillefond, Annick ^a   Debré, Bernard ^a   Lidereau, Rosette ^b   Amsellem Ouazana, Delphine ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CENTRE RENÉ HUGUENIN   (France)

Author keywords

Angiogenesis; Bladder cancer; Molecular marker; Prognostic factor; RT PCR; VEGFA

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 8; SCATTER FACTOR RECEPTOR; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69249205704     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.05.027     Document Type: Article

References (30)

1. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
2. Folkman J. What is the evidence that tumours are angiogenesis dependent?. J Natl Cancer Inst 82 (1990) 4-6
3. Wu W., Shu X., Hovsepyan H., Mosteller, and Broek R.D. VEGF receptor expression and signaling in human bladder tumours. Oncogene 22 (2003) 3361-3370
4. Ladomery M.R., Harper S.J., and Bates D.O. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm. Cancer Lett 249 (2007) 133-142
5. Li N., Kanda K., Fukumori T., et al. Expression of vascular endothelial growth factor isoforms and platelet-derived endothelial cell growth factor in bladder cancer. Urol Oncol 6 (2000) 10-15
6. Oka N., Yamamoto Y., Takahashi M., Nishitani M., Kanayama H.O., and Kagawa S. Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer. BJU Int 95 (2005) 660-663
7. Inoue K., Slaton J.W., Kim S.J., et al. Interleukin 8 expression regulates tumourigenicity and metastasis in human bladder cancer. Cancer Res 60 (2000) 2290-2299
8. Izawa J.I., Slaton J.W., Kedar D., Karashima T., Perrotte P., Czerniak B., et al. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol Rep 8 (2001) 9-15
9. Grossfeld G.D., Ginsberg D.A., Stein J.P., et al. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumour angiogenesis, and tumour progression. J Natl Cancer Inst 89 (1997) 219-227
10. Campbell S.C., Volpert O.V., Ivanovich M., and Bouck N.P. Molecular mediators of angiogenesis in bladder cancer. Cancer Res 58 (1998) 1298-1304
11. Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
12. Cao Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 5 (2005) 735-743
13. Shinkaruk S., Bayle M., Lain G., and Deleris G. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy. Curr Med Chem Anticancer Agents 3 (2003) 95-117
14. Crew J.P. Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer. Eur Urol 35 (1999) 2-8
15. Bartoletti R., Cai T., Nesi G., Sardi I., and Rizzo M. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. Oncol Rep 14 (2005) 251-255
16. Chow N.H., Liu H.S., Chan S.H., Cheng H.L., and Tzai T.S. Expression of vascular endothelial growth factor in primary superficial bladder cancer. Anticancer Res 19 (1999) 4593-4597
17. Theodoropoulos V.E., Lazaris A.C., Sofras F., et al. Hypoxia-inducible factor 1α expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 46 (2004) 200-208
18. Jones A., and Crew J. Vascular endothelial growth factor and its correlation with superficial bladder cancer recurrence rates and stage progression. Urol Clin North Am 27 (2000) 191-197
19. Inoue K., Slaton J.W., Karashima T., et al. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res 6 (2000) 4866-4873
20. Crew J.P., O'Brien T., Bicknell R., Fuggle S., Cranston D., and Harris A.L. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol 161 (1999) 799-804
21. Molinie V. Classification des tumeurs de vessie en 2006. Prog Urol FMC 16 (2006) 7-10
22. IUAC TNM Classification of Malignant Tumors. 6th ed. New York: John Wiley & Sons; 2002.
23. Bieche I., Onody P., Tozlu S., Driouch K., Vidaud M., and Lidereau R. Prognostic value of ERBB family mRNA expression in breast carcinomas. Int J Cancer 106 (2003) 758-765
24. Amsellem-Ouazana D., Bièche I., Molinié V., Elie C., Vieillefond A., Tozlu S., et al. Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?. Eur Urol 49 (2006) 1035-1043
25. Turner K.J., Crew J.P., Wykoff C.C., Watson P.H., Poulsom R., Pastorek J., et al. The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer. Br J Cancer 86 (2002) 1276-1282
26. Beecken W.D., Engl T., Hofmann J., Jonas D., and Blaheta R. Clinical relevance of serum angiogenic activity in patients with transitional cell carcinoma of the bladder. J Cell Mol Med 9 (2005) 655-661
27. Yang C.C., Chu K.C., and Yeh W.M. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression. Urol Oncol 22 (2004) 1-6
28. Sato K., Sasaki R., Ogura Y., et al. Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer. Tohoku J Exp Med 185 (1998) 173-184
29. Slaton J.W., Millikan R., Inoue K., Karashima T., Czerniak B., Shen Y., et al. Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. J Urol 171 (2004) 570-574
30. Stavropoulos N.E., Bouropoulos C., Ioachim I.E., et al. Prognostic significance of angiogenesis in superficial bladder cancer. Int Urol Nephrol 36 (2004) 163-167